A majority of patients with cancer don’t understand critical features of the genomic test results they receive when participating in clinical trials, according to a pilot study conducted under...
In a first-of-its-kind partnership in Illinois, OSF HealthCare Children’s Hospital is joining forces with Rady Children’s Institute for Genomic Medicine (RCIGM) on a precision medicine...
The FDA Oncology Center for Excellence (OCE) and Syapse have signed a multi-year Research Collaboration Agreement (RCA) focused on using real-world evidence to support regulatory decision-making in...
Researchers from Massachusetts General Hospital (MGH) have found that mild or moderate depression together with brain amyloid, a biological marker of Alzheimer’s disease, could result in changes...
Artificial intelligence could improve key parts of the clinical trial process, including selection and recruitment and patient monitoring, according to a study published in Trends in Pharmacological...
Temple University, NIH, and the University of Pittsburgh will partner to open an enrollment site for the All of Us Research Program, an effort to advance precision medicine treatment and care for...
Machine learning technologies can help predict outcomes of clinical trials, leading to faster drug approval times, lower costs, and more funding to develop new treatments, according to a study...
One hundred percent of clinical trial sponsors cite the need for better data exchange among study partners, indicating that the industry is pushing for more streamlined trial processes and systems, a...
Data management platforms and financial incentives may help organizations increase cancer clinical trial enrollment and patient recruitment, states a study published in the Journal of Clinical...
Using multi-drug therapies helped improve outcomes among patients with therapy-resistant cancers, indicating that combination drug treatments could improve precision medicine for cancer care, according...
FDA has issued draft guidance discussing how sponsors can enhance the diversity of populations in clinical trials.
While the agency noted that it has made progress in increasing enrollment diversity,...
The National Institutes of Health (NIH) will fund clinical trials to assess the benefits, applicability, and efficacy of applying genomic medicine to chronic disease management.
The trials are part of...
The NCI-MATCH precision medicine clinical trial, co-led by the ECOG-ACRIN Cancer Research Group and the National Cancer Institute (NCI), has released findings revealing that a particular drug...
FDA is working to eliminate health disparities in clinical trials, research, and treatments of chronic, debilitating diseases.
The agency needs to increase equity across the care continuum, stated a...
The FDA, Brigham and Women’s Hospital, and Aetion are expanding their real-world evidence demonstration project to predict the results of seven ongoing Phase IV trials.
The project,...
Real-world data gathered directly from EHRs and other data sources, paired with advances in machine learning, will be crucial for architecting the next generation of successful clinical trials, says...
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence have launched an initiative to provide timely and accurate estimates of the risks and benefits of clinical trials to...
The National Cancer Institute (NCI) has revised its clinical trial protocol template to expand eligibility criteria for cancer clinical trials. The updated criteria will allow patients with certain...
The FDA has introduced the new MyStudies app, which will collect real-world evidence through mobile devices and increase the diversity of information available for clinical trials and other healthcare...
The FDA is turning to cost-effective strategies and big data to accelerate clinical trial efficiency, medical product development, and innovations in artificial intelligence, according to a recent blog...
